Choice of Insulin and Pump Device

The recommended insulin for pump use is a rapid acting insulin analogue, e.g. Humalog^®, NovoRapid^® or Apidra^®.

The choice of insulin pump should be at the discretion of the doctor and the patient. Device-specific factors to consider include, inter alia:

• Device size.
• Reservoir size.
• Screen size.
• Ease of programmability.
• Computer software and download and upload capabilities.
• Minimum-dose adjustment increment for basal and bolus rates.
• Water-tightness.
• Compatibility with glucose monitoring devices.
• Cost of device and consumables.
• Device support from the manufacturer.

The recommendations presented herein are not meant to replace the judgement and discretion of physicians who treat individual patients, but rather to formulate guidelines to facilitate their work. This guideline will be reviewed every two years, or sooner, if necessary.